Latest Insider Transactions at Abeona Therapeutics Inc. (ABEO)
This section provides a real-time view of insider transactions for Abeona Therapeutics Inc. (ABEO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ABEONA THERAPEUTICS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ABEONA THERAPEUTICS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2023
|
Michael Amoroso Director |
SELL
Open market or private sale
|
Direct |
327
-0.28%
|
$981
$3.9 P/Share
|
|
Sep 19
2023
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+0.62%
|
$9,000
$3.76 P/Share
|
|
Sep 18
2023
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Open market or private purchase
|
Direct |
3,000
+1.58%
|
$9,000
$3.8 P/Share
|
|
Jul 24
2023
|
Joseph Walter Vazzano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,187
-0.5%
|
$3,561
$3.73 P/Share
|
|
Jun 20
2023
|
Michael Amoroso Director |
SELL
Open market or private sale
|
Direct |
338
-0.29%
|
$1,352
$4.45 P/Share
|
|
Jun 14
2023
|
Leila Alland Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+42.59%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Donald A. Wuchterl Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+42.59%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+38.38%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Faith L. Charles Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+42.59%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Michael Amoroso Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+33.76%
|
$234,756
$4.62 P/Share
|
|
Jun 14
2023
|
Mark Alvino Director |
BUY
Grant, award, or other acquisition
|
Direct |
58,689
+43.5%
|
$234,756
$4.62 P/Share
|
|
Jun 05
2023
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
90,902
+33.02%
|
-
|
|
Jun 05
2023
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,908
+37.51%
|
-
|
|
Jun 05
2023
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
336,826
+40.17%
|
-
|
|
Jun 02
2023
|
Vishwas Seshadri Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
827
-0.5%
|
$2,481
$3.06 P/Share
|
|
Apr 25
2023
|
Mark Alvino Director |
SELL
Open market or private sale
|
Direct |
887
-4.82%
|
$2,661
$3.25 P/Share
|
|
Apr 03
2023
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-0.11%
|
$208
$2.82 P/Share
|
|
Mar 20
2023
|
Michael Amoroso Director |
SELL
Open market or private sale
|
Direct |
268
-0.47%
|
$536
$2.33 P/Share
|
|
Mar 15
2023
|
Joseph Walter Vazzano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
792
-0.83%
|
$1,584
$2.6 P/Share
|
|
Mar 03
2023
|
Michael Amoroso Director |
SELL
Open market or private sale
|
Direct |
1,002
-1.74%
|
$2,004
$2.38 P/Share
|
|
Mar 03
2023
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-0.22%
|
$414
$2.28 P/Share
|
|
Dec 09
2022
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Open market or private purchase
|
Direct |
5,869
+5.89%
|
$17,607
$3.13 P/Share
|
|
Nov 18
2022
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Open market or private purchase
|
Direct |
7,500
+7.86%
|
$22,500
$3.99 P/Share
|
|
Nov 18
2022
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+2.56%
|
$10,000
$4.0 P/Share
|
|
Oct 17
2022
|
Vishwas Seshadri Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-0.12%
|
$828
$4.3 P/Share
|
|
Sep 28
2022
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
72,750
+47.48%
|
-
|
|
Sep 28
2022
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,200
+48.33%
|
-
|
|
Sep 28
2022
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,750
+43.96%
|
-
|
|
Sep 26
2022
|
Donald A. Wuchterl Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+39.63%
|
-
|
|
Sep 26
2022
|
Mark Alvino Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+42.12%
|
-
|
|
Sep 26
2022
|
Paul Elliot Mann Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+44.21%
|
-
|
|
Sep 26
2022
|
Todd Wider Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+44.21%
|
-
|
|
Sep 26
2022
|
Michael Amoroso Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+18.84%
|
-
|
|
Sep 26
2022
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+27.39%
|
-
|
|
Sep 26
2022
|
Leila Alland Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+39.63%
|
-
|
|
Sep 26
2022
|
Faith L. Charles Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,400
+39.63%
|
-
|
|
Sep 21
2022
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-5.02%
|
$1,437
$3.72 P/Share
|
|
Jul 21
2022
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+37.5%
|
-
|
|
Jun 15
2022
|
Mark Alvino Director |
SELL
Open market or private sale
|
Direct |
20,000
-42.39%
|
$0
$0.15 P/Share
|
|
Jun 06
2022
|
Mark Alvino Director |
SELL
Open market or private sale
|
Direct |
35,000
-42.59%
|
$0
$0.16 P/Share
|
|
Jun 01
2022
|
Vishwas Seshadri Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
81,525
-23.29%
|
$0
$0.16 P/Share
|
|
Mar 14
2022
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+50.0%
|
-
|
|
Dec 06
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
8,880
-4.16%
|
$0
$0.57 P/Share
|
|
Nov 05
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
8,880
-3.99%
|
$0
$0.89 P/Share
|
|
Oct 15
2021
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+12.5%
|
-
|
|
Oct 11
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
25,734
-10.37%
|
$0
$0.9 P/Share
|
|
Oct 08
2021
|
Edward Carr Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,122
-6.78%
|
$29,122
$1.05 P/Share
|
|
Oct 08
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
22,763
-8.4%
|
$22,763
$1.05 P/Share
|
|
Oct 07
2021
|
Todd Wider Director |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$0
$0.97 P/Share
|
|
Oct 05
2021
|
Brendan M. O'Malley SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
2,447
-0.89%
|
$2,447
$1.05 P/Share
|